Adventrx Pharmaceuticals, Inc.
6725 Mesa Ridge Road
Suite 100
San Diego, CA 92121
United States - Map
Phone: 858-552-0866
Fax: 858-552-0876
Web Site: http://www.adventrx.com

ADVENTRX Pharmaceuticals, Inc., a biopharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates for the treatment of cancer. Its lead product candidates include ANX-530, a novel emulsion formulation of chemotherapy drug vinorelbine to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, as well as to treat advanced or metastatic breast cancer; and ANX-514, a novel emulsion formulation of the chemotherapy drug docetaxel for the treatment of breast, non-small cell lung, prostate, gastric, and head and neck cancers. The company was founded in 1995 is based in San Diego, California.

Index Membership:	N/A
Sector:	Healthcare
Industry:	Biotechnology
Full Time Employees:	2

Adventrx Pharmaceuticals, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Mar-10 is better than 96.9% of CGQ Universe companies and 90% of Pharmaceuticals, Biotechnology & Life Sciences companies.

Executive	Pay	Excercised
Mr. Brian M. Culley M.S., M.B.A., 38 Principal Exec. Officer, Chief Bus. Officer and Sr. VP of Bus. Devel.	N/A	N/A
Mr. Patrick L. Keran J.D., 38 Pres, Chief Operating Officer, Interim Principal Financial Officer, Interim Principal Accounting Officer, VP of Legal, Sec. and Gen. Counsel	$ 231.00K	N/A
Mr. Mark N.K. Bagnall C.P.A., 53 Consultant	$ 272.00K	N/A
Mr. Mark E. Erwin , 45 Sr. VP of Operations	N/A	N/A
Ms. Michele L. Yelmene , 46 VP of Regulatory Affairs	N/A	N/A